COVID-19 rapid antigen test notified to BfArM
We are happy to announce that Vakzine Projekt Management GmbH (VPM) together with Grit Overseas Pte. Ltd. in Singapore successfully notified a COVID-19 rapid antigen test to the German Institute for Pharmaceuticals and Medical Products (BfArM).
"The DiagnoSure SARS-CoV-2 Antigen Rapid Test is now available and will get reimbursed by the health insurance upon prescription by a doctor.", says Oorvahsk F. Dastoor, Managing Director of Grit Overseas.
The test detects the viral N-protein and is therefore applicable for all virus mutants independent of mutations in their spike protein. This allows a reliable and fast detection of SARS-CoV-2 for everyone.
"We are proud to be involved to make an additional rapid antigen test accessible to the public in this COVID-19 pandemic", says Dr. Leander Grode, Managing Director of VPM. This is the first medicinal product VPM was involved in.